ArticleInternational journal of hematology2025

Factor X consumption attenuates the coagulation effect of emicizumab: a case of severe hemophilia A treated with emicizumab and factor VIII-bypassing agents.

Kuniyoshi Mizumachi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.